Speaker: Ms. P. Dhanishta
Synergistic Starvation and Photodynamic Therapy of Cancer
Date & Time: Thursday 21st September, 2017 at 4.00 PM
Venue: SSCU AUDITORIUM
Selectively cuting off the nutrient supply and the metabolism pathways of cancer cells would be a promising approach to improve the efficiency of cancer treatment. Here, a cancer targeted cascade bioreactor (designated as mCGP) was constructed for synergistic starvation and photodynamic therapy (PDT) by embedding glucose oxidase (GOx) and catalase in the cancer cell membrane-camouflaged porphyrin metal−organic framework (MOF) of PCN-224 (PCN stands for porous coordination network). Due to biomimetic surface functionalization and homotypic targeting behaviors of mCGP would dramatically enhance its cancer targeting and retention abilities. Once internalized by cancer cells, mCGP was found to promote microenvironmental oxygenation by catalyzing the endogenous hydrogen peroxide (H2O2) to produce oxygen (O2), which would subsequently accelerate the decomposition of intracellular glucose and enhance the production of cytotoxic singlet oxygen (1O2)under light irradiation. Consequently, mCGP displayed amplified synergistic therapeutic effects of long-term cancer starvation therapy and robust PDT, which would efficiently inhibit the cancer growth after a single administration. This cascade bioreactor would further facilitate the development of complementary modes for spatiotemporally controlled cancer treatment.
1. Jonathan F. Lovell,† Tracy W. B. Liu,‡ Juan Chen,‡ and Gang Zheng*†,‡, Chem. Rev., 2010,110, 2839–2857
2. Shi-Ying Li,† Hong Cheng,† Bo-Ru Xie,† Wen-Xiu Qiu,†, ACS Nano, 2017, 11, 7006−7018.
3. Jihye Park,† Qin Jiang,‡ Dawei Feng,† Lanqun Mao,*,‡ and Hong-Cai Zhou*,†,J. Am. Chem. Soc., 2016, 138, 3518−3525.
4. Aisling E. O’Connor1, William M. Gallagher1 and Annette T. Byrne*1,2, Photochemistry and Photobiology, 2009, 85, 1053–1074.
ALL ARE CORDIALLY INVITED TO ATTEND